Atturos
Atturos is a clinical diagnostics company spun out from University College Dublin, developing advanced molecular diagnostic tests using targeted proteomics and machine learning to support clinicians in treatment decisions. Their proprietary platform measures ultra-low protein biomarker concentrations with high specificity and sensitivity via mass spectrometry, enabling multiplexed protein quantification. Atturos focuses on unmet clinical needs in chronic diseases, with a pipeline including tests for inflammatory arthritis, prostate cancer, and diabetic kidney disease. The company combines scientific excellence with AI-driven analytics to provide easy-to-interpret scores for improved patient outcomes. Atturos operates with a patient-centric approach and collaborates internationally, leveraging its advanced proteomics platform for ongoing test development and commercialization.
Atturos
Atturos is a clinical diagnostics company spun out from University College Dublin, developing advanced molecular diagnostic tests using targeted proteomics and machine learning to support clinicians in treatment decisions. Their proprietary platform measures ultra-low protein biomarker concentrations with high specificity and sensitivity via mass spectrometry, enabling multiplexed protein quantification. Atturos focuses on unmet clinical needs in chronic diseases, with a pipeline including tests for inflammatory arthritis, prostate cancer, and diabetic kidney disease. The company combines scientific excellence with AI-driven analytics to provide easy-to-interpret scores for improved patient outcomes. Atturos operates with a patient-centric approach and collaborates internationally, leveraging its advanced proteomics platform for ongoing test development and commercialization.